Gene · 407047
Papers2,619
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,619
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Cells Release MicroRNA-155 Enriched Extracellular Vesicles That Promote HIV-1 Infection. | Cells | 2023 | 36766808 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes. | Animals (Basel) | 2023 | 36766357 | PubTator, text mining | PubMed |
| Post-transcriptional regulation in cranial neural crest cells expands developmental potential. | Proc Natl Acad Sci U S A | 2023 | 36724256 | PubTator, text mining | PubMed |
| Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism. | Sci Rep | 2023 | 36717592 | PubTator, text mining | PubMed |
| Exosomal miR-205-5p derived from periodontal ligament stem cells attenuates the inflammation of chronic periodontitis via targeting XBP1. | Immun Inflamm Dis | 2023 | 36705422 | PubTator, text mining | PubMed |
| Nano-Based Drug Delivery of Polyphenolic Compounds for Cancer Treatment: Progress, Opportunities, and Challenges. | Pharmaceuticals (Basel) | 2023 | 36678599 | PubTator, text mining | PubMed |
| Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy? | J Clin Med | 2023 | 36675594 | PubTator, text mining | PubMed |
| Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases. | J Clin Transl Hepatol | 2023 | 36643031 | PubTator, text mining | PubMed |
| Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer. | Cell Commun Signal | 2023 | 36639674 | PubTator, text mining | PubMed |
| Targeting miR-5088-5p attenuates radioresistance by suppressing Slug. | Noncoding RNA Res | 2023 | 36632615 | PubTator, text mining | PubMed |
| Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. | Funct Integr Genomics | 2023 | 36625940 | PubTator, text mining | PubMed |
| In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines | Iran Biomed J | 2023 | 36624663 | PubTator, text mining | PubMed |
| miRNA‑92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in‑stent restenosis. | Mol Med Rep | 2023 | 36601739 | PubTator, text mining | PubMed |
| Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes. | J Pharmacol Exp Ther | 2023 | 36549862 | PubTator, text mining | PubMed |
| Systematic characterization and biological functions of non-coding RNAs in glioblastoma. | Cell Prolif | 2023 | 36457281 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. | Cancer Commun (Lond) | 2023 | 36424360 | PubTator, text mining | PubMed |
| Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide. | J Pharmacol Exp Ther | 2023 | 36410793 | PubTator, text mining | PubMed |
| Role of miRNAs in vascular development. | Noncoding RNA Res | 2023 | 36262425 | PubTator, text mining | PubMed |
| Emerging role of extracellular vesicles in the pathogenesis of glioblastoma. | Metab Brain Dis | 2023 | 36083425 | PubTator, text mining | PubMed |
| VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma. | Biomol Biomed | 2023 | 36036061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407047/papers?page=9